Professor of Health Policy and Administration
School of Public Health
University of Illinois at Chicago (UIC)
J. Warren Salmon, Ph.D. was Professor of Health Policy and Administration, School of Public Health at the University of Illinois at Chicago (UIC), now retired but actively engaged in research still. He was formerly a Professor in and Head of the Department of Pharmacy Administration, College of Pharmacy; Professor of Public Policy Analysis, College of Urban Planning and Public Affairs; and Professor of Medical Education, College of Medicine at UIC. Professor Salmon's research interests have focused on the corporatization of medicine and pharmacy, managed care pharmacy, urban health care delivery, comparative health care systems, global pharmaceutical industry developments, and alternative and complimentary medicines.
Nanotechnology and Advanced Materials (NATAM)
Chemical and Nanopharmaceutical Process Engineering
Professor Sivakumar Manickam is a Chemical Engineer specializing Process Engineering of Nanomaterials especially Nanopharmaceuticals. He is working in the area of Ultrasound and Hydrodynamic Cavitation since 1997. Presently he is working with University of Nottingham, Malaysia campus and his research group concentrates on the process development of cavitation based reactors towards technologically important nanomaterials. He is also heading the Manufacturing and Industrial Processes Research Division and is the Coordinator of the Centre for Nanotechnology and Advanced Materials (CENTAM). He was also the recipient of prestigious JSPS fellowship from the Government of Japan. He has published ~150 peer reviewed journal and conference papers. He is the Fellow of Higher Education Academy (UK) and member of Institute of Nanotechnology (IoN).
UNESCO Chair-Life Sciences International
Postgraduate Educational Center
Prof. Sinerik Ayrapetyan has received his PhD in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev during the period of 1966-1970. Currently, he is the coordinator of UNESCO Chair at Life Sciences International Postgraduate Educational Center, Yerevan, Armenia. He has successfully completed his Administrative responsibilities as the president of Life Sciences International Postgraduate Educational Center. His research has included the study of metabolic regulation of cell function in norm and pathology. He is serving as an editorial member of several reputed journals like “Electromagnetic Biology and Medicine”, “ISRN Biophysics”, “European Journal of Biophysics”, “Advances in Life Sciences", “Bioavailability and Bioequivalence”, “Applied Pharmacy”, “BBA General Subjects”, “International Dental and Medical Research", “International Journal of Basic and Applied Sciences” & expert Reviewer for journals like “Brain research”, “Radiobiology”, “Bioelectromagnetics”, “Journal of Alzheimer’s diseases”, “Life Sciences” etc. He has authored 7 international books and 115 research articles.
Prof. XU, Baojun Bruce is a Professor of Food Science and Technology department at University of Illinois at Chicago, USA.
His research interest includes 1) health benefits (targeted at aging, cancers, obesity, diabetes, and inflammatory diseases) assessment of phytochemicals from legumes, fruits, vegetables, traditional Chinese medicines through in vitro animal cell models; 2) cellular and molecular mechanisms of bioactive food components in disease prevention; 3) development of novel health promoting products and cosmeceuticals; 4) lab-scale and pilot scale extraction techniques of natural functional polysaccharides.
Well-trained nephrologist and founder, CEO, and Chief Medical Officer of GenoMed, a Next Generation DM(tm) company (DM = Disease Management). GenoMed is a patient-friendly company which does business over the Internet. It is the only player in healthcare to use cutting-edge, genomics-based medicine to lower healthcare costs. We are pioneers in preventive molecular medicine. We are revolutionizing healthcare--converting it from an anti-patient, increasingly expensive, largely futile, hospital-based industry to a patient-friendly, inexpensive, outpatient-based exercise in effective prevention of disease.
Professor, Microbiology and Immunology
Professor, Center for Translational Medicine
Temple University, USA
Dr. Praticò’s research area is clinical pharmacology with a special focus on the cellular and molecular aspects of cell oxidative biology and a particular interest in small molecules such as bioactive oxidized lipids.
This area is very broad and extends to multiple disciplines including aging, cardiovascular diseases as well as neurodegeneration. Our work in the biology of oxidized bioactive lipids has significantly contributed to the current understanding of their importance as biomarkers, mediators of cellular and molecular events involved in the pathogenesis of several clinical conditions, and therapeutic targets for preventing and treating human diseases. In our lab we employ cellular and animal models of human diseases, and in this context particular emphasis is given to the translation of any observation made in these systems into a better understanding of human physiology and pathology. Our group is committed to foster collaborative scientific research of the highest quality, and at the same time to provide outstanding teaching and mentoring for young scientists.
Founder, Oxford Molecular
Chairmen, Inhibox Limited
Oxford center of innovation
Prof. Graham Richards CBE recently retired from Oxford University where he was Head of the Department of Chemistry 1997-2006, the world’s biggest chemistry department. His research focused on the applications of theoretical chemistry to drug discovery and he devised the widely publicized screensaver project which involved over 3.5 million personal computers in more than 200 countries. He now operates from the drug discovery company Inhibox Ltd.
He is the author of over 360 scientific papers and 18 books, including ‘Spin- outs: creating businesses from university intellectual property’ and the recently published ‘University Intellectual Property: a source of finance and impact’. He has consulted for several major pharma companies and is now senior non-executive director of IP Group Plc as well as holding a number of other directorships of biotechnology companies.
Prof. Singab is a professor of pharmacognosy and the Dean of the School of Pharmacy, Ain Shams University, Cairo, Egypt. He is specialized in research on medicinal herbs and botanical investigation for drug discovery using contemporary analysis methods. He is the founder of "Centre for Drug Discovery and Research Development” in 2013.
Dr. Mirza R. Baig is currently working as a Professor in Clinical Pharmacy in Dubai Pharmacy College, Dubai, United Arab Emirates. He did his PhD in Clinical Pharmacy from University Science Malaysia (USM), Malaysia. He worked in Malaysia, India and have international teaching experience of about 14 years. He worked as an Acting Dean for a brief period in AIMST University, Malaysia. He published 4 books related to Clinical Pharmacy and Pharmaceutical Care. He published more than 30 Research papers and articles in International Journals. He is in the editorial board in various international journals and He is a reviewer for couple of Elsevier journals. He received couple of awards in his career, one of it as a young scientist award in Malaysia, Best Presentation for the research project in DUPHAT 2015 in Dubai, Best presentation award in IPC 2003, in India.
Dr. Mohamed Eddouks is currently working as a professor at Moulay ismail university, morocco. He worked as assistant professor at faculty of sciences and techniques errachidia (1995) and as head of the department of biology at faculty of sciences and techniques errachidia (2003). He completed his PhD degree in Physiology and Pharmacology from University of Liege, Belgium and Sidi Mohammed Ben Abdellah University. He published many articles in international journals.
Karen Mulkijanyan is the Head of the Department of Pharmacology at Tbilisi State Medical University Institute of Pharmacochemistry and Adviser on Technology Commercialization to aforesaid Institute’s Administration. He obtained his MS in Biochemistry in 1981 and PhD in Pharmacy in 2005. Dr. Mulkijanyan’s research interests include studying the pharmacology of anti-inflammatory and wound healing drugs and analysis and prediction of structure-activity relationship of natural, modified and synthesized compounds. He is the author and co-author of more than 90 papers in peer-reviewed journals, about 30 presentations at international scientific meetings, and 2 patents.
Dr. Rameshwar K. Sharma is the Distinguished Professor of Biochemistry and Molecular Biology at the Salus University, Elkins Park, Pennsylavania. In a period spanning four decades Dr. Sharma's research team has been involved in the cellular signal transduction reseach in mammalian systems. Dr. Sharma has trained and guided more than 35 doctoral and post-doctoral fellows, authored 180 peer-reviewd research articles, including the editorship of two two books and the Special Editorship of two journals of the Molecular and Cellular Biochemistry focused on the field of membrane guanylate cyclases. A present he is on the editorial board of the three international journals: Molecular and Cellular Biochemistry, J Signal Transduction, J Memabrane Science & Technology. He is the recipeint of the Medal of Merit from the International Society of Heart and Hypertension.
Huixiao Hong, Ph.D., is a senior Scientist at the Division of Systems Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Arkansas, USA, working on the scientific bases for regulatory application and development of genomics and biomarkers at the FDA. Before he joined the FDA, he was a senior Bioinformatician and the Manager of Bioinformatics Division at Z-Tech, an ICFI company. He held a Research Scientist position at Sumitomo Chemical Company in Japan. He was a visiting scientist at National Cancer Institute (NCI) at National Institutes of Health (NIH). He was also an Associated Professor and the Director of Laboratory of Computational Chemistry at Nanjing University in China. He published more than 80 scientific papers and served as an Executive Editor or a member of Editorial Board of 9 peer-reviewed journals and as a reviewer of more than 20 peer-reviewed journals in the area of pharmacogenomics, proteomics, bioinformatics, and chemoinformatics. He received his Ph.D. from Nanjing University in China and did post-doctoral research at Maxwell Institute in Leeds University in England.
Exec. Vice President and Chairman,PRI
Vice Provost of Research, ACPHS
Professor of Pharmacology, ACPHS
Pharmaceutical Research Institute (PRI) Executive Vice President and Chairman Shaker A. Mousa, Ph.D., MBA, FACC, FACB, has demonstrated throughout his distinguished career the ability to bring novel concepts from "the bench to the bedside." Dr. Mousa came to Albany College of Pharmacy and Health Sciences in 2002 following a career of more than 17 years as a principal research scientist at DuPont Pharmaceuticals Co. Dr. Mousa is also a visiting scholar at The Johns Hopkins University and holds academic appointments of adjunct professor in the Department of Medicine at Temple University's Sol Sherry Thrombosis Research Center, the Department of Medicine of the State University of New York at Buffalo, and the Department of Pharmacology of the University of Pennsylvania.
Dr. Coffin has joined Ross in October, 2009 as an Associate Professor in the Pharmacology after spending 20 plus years in drug research, development and licensing in the Pharmaceutical industry. Dr. Coffin has a B.S. in biology from The Pennsylvania State University in State College, PA and a Ph.D. in Pharmacology from The University of Oklahoma Health Sciences Center, Oklahoma City, OK. She did her postdoctoral training at Wayne State University School of Medicine and at Harvard Medical School, Southborough MA. Her research focused on adenosine agonists and antagonists actions on behavior, blood pressure and heart rate. She continued her research career at Schering Plough Research Institute and focused on the pharmacological actions of dopamine, acetylcholine, glycine and neurokinins. Besides experience with drug development she also was a Sr. Director for Business Licensing with Schering Corporation and active in licensing with VC Pharma Consulting.
Dr. Weiner is widely known toxicologist with expertise on food additives and ingredients. During her thirty years as an corporate research toxicologist, her responsibilities included safety assessment of existing and new products; designing and directing toxicology studies; and interfacing with trade associations and regulatory agencies on a global basis. Her publications include over forty peer-reviewed articles on food additives, pharmaceutical excipients, industrial chemicals, drugs and pesticides. Dr. Weiner has participated in numerous international meetings and task forces. She co-edited Excipient Toxicity and Safety (Marcel Dekker, 1999), and was the recipient of the 2011 Marshall Steinberg Memorial Award from the International Pharmaceutical Excipients Council Foundation for outstanding contributions and achievements in excipient safety. She has been a Diplomate of the American Board of Toxicology for thirty years and a Fellow of the Academy of Toxicological Scientists for seven years. Dr. Weiner earned a B.A. in Biology cum laude from Stern College for Women; a Ph.D. in Pharmacology from Downstate Medical Center, the State University of New York, and completed a postdoctoral appointment at the Research Institute of Pharmaceutical Sciences, University of Mississippi. Currently, she is a consultant for her firm, TOXpertise, LLC.
Ye Xu is currently working in Jilin Medical University. He served on many institutional, national, and international committees and advisory boards. He has successfully organized and directed many scientific meetings and symposia and managed many multi-institutional and international collaborative research projects and programs. He has actively contributed to the scientific community through publication, meeting presentations, and lectures worldwide.